Skip to main content
Log in

Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to investigate expression of CD147 and MMP-9 in salivary duct carcinoma (SDC) so as to determine whether these two genes may be correlated with poor prognosis of SDC.

Methods

We examined the significance of the CD147 and MMP-9 expression in SDC (n = 35), non-cancerous salivary tissue (n = 20) in previously untreated patients using immunohistochemical staining. Furthermore, we analyzed the correlation between the expression of these two genes and various clinicopathologic factors including survival status of patients with SDC.

Results

Positive stain of CD147 and MMP-9 was seen in all 35 cases of tumor samples. A statistical correlation was observed between CD147 and MMP-9 expression in SDC tissues. The incidences of high expression were 45.71% for CD147 and 51.43% for MMP-9 in 35 SDC tissues, respectively. High expression of CD147 and MMP-9 was significantly correlated with clinical feature and shorter progression-free survival (PFS) (P CD147 = 0.031; P MMP-9 = 0.020) and overall survival (OS) (P CD147 = 0.044; P MMP-9 = 0.013).

Conclusion

CD147 and MMP-9 expression is correlated with invasion, metastasis and shorter PFS/OS of SDC. Patients with high expression of CD147 and MMP-9 had poor prognosis than SDC patients with low expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Backstrom JR, Tokes ZA (1995) The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J Neurochem 64:1312–1318

    Article  PubMed  CAS  Google Scholar 

  • Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S (2010) MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest 28:38–43

    Article  PubMed  CAS  Google Scholar 

  • Biswas C, Zhang Y, DeCastro R et al (1995) The human tumor cell-derived collagenase stimulatory factor (re-named EMMPRIN) is a member of the immunoglobulin super family. Cancer Res 55:434–439

    PubMed  CAS  Google Scholar 

  • Bourguignon L, Gunja-Smith Z, Iida N et al (1998) CD44v (3, 8–10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176:206–215

    Article  PubMed  CAS  Google Scholar 

  • Butterworth DM, Jones AW, Kotecha B (1992) Salivary duct carcinoma: Report of case and review of the literature. Virchows Arch 420:371–374

    Article  CAS  Google Scholar 

  • Chen X, Lin J, Kanekura T et al (2006) A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res 66:11323–11330

    Article  PubMed  CAS  Google Scholar 

  • Davidson B, Goldberg I, Berner A et al (2003) EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 20:161–169

    Article  PubMed  CAS  Google Scholar 

  • Fridman R, Toth M, Pena D, Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548–2555

    PubMed  CAS  Google Scholar 

  • Guo H, Li R, Zucker S et al (2000) EMMPRIN (CD147), aninducer of matrix metalloproteinase synthesis, also bindsinterstitial collagenase to the tumor cell surface. Cancer Res 60:888–891

    PubMed  CAS  Google Scholar 

  • Jaehne M, Roeser K, Jaekel T et al (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103:2526–2533

    Article  PubMed  Google Scholar 

  • Ju XZ, Yang JM, Zhou XY et al (2008) EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer. Clin Cancer Res 14:494–501

    Article  PubMed  CAS  Google Scholar 

  • Juarez J, Clayman G, Nakajima M, Tanabe KK, Saya H, Nicolson GL et al (1993) Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer 55:10–18

    Article  PubMed  CAS  Google Scholar 

  • Kleinsasser O, Klein HJ, Hubner G (1968) Salivary duct carcinoma: a group of salivary gland tumors analogous to mammary duct carcinoma. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 192:100–105

    Article  PubMed  CAS  Google Scholar 

  • Lewis JE, Mckinney BC, Weiland LH, Ferreiro JA, Olsen KD (1996) Salivary duct carcinoma: clinicopathologic and immunohistochemical review of 26 cases. Cancer 77:223–230

    Article  PubMed  CAS  Google Scholar 

  • Lewis JE, Olsen KD, Sebo TJ (2001) Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 32:596–604

    Article  PubMed  CAS  Google Scholar 

  • Li Z, Ren Y, Wu QC et al (2004) Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. Chin Med J 117:107–114

    PubMed  CAS  Google Scholar 

  • Li Y, Jing X, Li C et al (2009) HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology 54:677–687

    Article  PubMed  CAS  Google Scholar 

  • Liotta LA, Stetler-Stevenson WG, Steeg PS (1991) Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9:543–551

    Article  PubMed  CAS  Google Scholar 

  • Liu Z, Li L, Yang ZX et al (2010) Research article Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer 10:270

    PubMed  Google Scholar 

  • Lukkaa H, Klemi P, Hirsimaki P et al (2008) Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer. Acta Otolaryngol 128:482–490

    Article  Google Scholar 

  • Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H, Nagasue N (2000) Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6:4064–4068

    PubMed  CAS  Google Scholar 

  • Mira E, Lacalle RA, Buesa JM et al (2004) Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci 117:1847–1857

    Article  PubMed  CAS  Google Scholar 

  • Nakajima M, Welch DR, Belloni PN, Nicolson GL (1987) Degradation of basement membrane type IV collagen and lung subendothelialmatrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47:4869–4876

    PubMed  CAS  Google Scholar 

  • Overall C, López-Otín C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657–672

    Article  PubMed  CAS  Google Scholar 

  • Ramos-DeSimone N, Hahn-Dantona E, Sipley J et al (1999) Activation of matrix metalloprotease-9 (MMP-9) viaa converting Plasmin/Stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274:13066–13076

    Article  PubMed  CAS  Google Scholar 

  • Rao JS, Ra C, Gondi C et al (2005) Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther 4:1399–1408

    Article  PubMed  CAS  Google Scholar 

  • Sienel W, Hellers J, Morresi-Hauf A, Lichtinghagen R, Mutschler W, Jochum M, Klein C, Passlick B, Pantel K (2003) Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer. Int J Cancer 103:647–651

    Article  PubMed  CAS  Google Scholar 

  • Suzuki S, Sato M, Senoo H, Ishikawa K (2004) Direct cell–cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and Broblasts: involvement EMMPRIN Mt1-MMP. Exp Cell Res 293:259–266

    Article  PubMed  CAS  Google Scholar 

  • Tang J, Zhou HW, Jiang JL, Yang XM et al (2007) ßig-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells. Exp Biol Med 232:344–352

    CAS  Google Scholar 

  • Tanioka Y, Yoshida T, Yagawa T, Saiki Y, Takeo S, Harada T, Okazawa T, Yanai H, Okita K (2003) Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89:2116–2121

    Article  PubMed  CAS  Google Scholar 

  • Toole BP (2003) Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 54:371–389

    Article  PubMed  CAS  Google Scholar 

  • Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37:375–536

    Article  PubMed  Google Scholar 

  • Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, Zhang XM, Jin H, Liu L, Zhang YF, Liu J et al (2009) Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol 219:114–122

    Article  PubMed  CAS  Google Scholar 

  • Xu J, Shen ZY, Chen XG et al (2007) A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 45:269–276

    Article  PubMed  CAS  Google Scholar 

  • Yu WW, Liu JH, Xiong XL et al (2009) Expression of MMP-9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract 205:709–715

    Article  PubMed  CAS  Google Scholar 

  • Zhang Q, Chen XG, Zhou J et al (2006) CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients. Cancer Biol Ther 5:808–814

    Article  PubMed  CAS  Google Scholar 

  • Zhang Q, Zhou J, Ku XM et al (2007) Expression of CD147 as a significant unfavorable prognostic factor in hepatocellular carcinoma. Eur J Cancer Prev 16:196–202

    Article  PubMed  Google Scholar 

  • Zucker HymowitzM, Rollo EE et al (2001) Tumorigenicpotential of extracellular matrix metalloproteinase inducer. Am J Pathol 158:1921–1928

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China [Grant Number 81170960] and the Ministry of Education College Doctoral Degree Special Fund [Grant Number 20102307110006].

Conflict of interest

All authors declared that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bin Zhang.

Additional information

Songlin Piao and Shu Zhao contributed equally to the work and should be considered co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piao, S., Zhao, S., Guo, F. et al. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol 138, 627–635 (2012). https://doi.org/10.1007/s00432-011-1142-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-011-1142-6

Keywords

Navigation